Status: Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
Participants needed: 600
Trial details
Biological sex: AllType: ObservationalSponsor: GT Medical Technologies, Inc.Updated: Feb 13, 2026Locations: 54Duration: 5 Years
Eligibility criteria
Patients who undergo maximum safe resection of intracranial neoplasm(s) AND impl... [+1]
Inability to undergo pre-operative and post-operative imaging for disease and im... [+2]